Profile data is unavailable for this security.
About the company
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
- Revenue in USD (TTM)1.29m
- Net income in USD-91.82m
- Incorporated2020
- Employees159.00
- LocationQuantum-Si Inc29 Business Park DriveBRANFORD 06405United StatesUSA
- Phone+1 (203) 458-7100
- Fax+1 (302) 636-5454
- Websitehttps://www.quantum-si.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CervoMed Inc | 9.49m | -593.84k | 152.20m | 8.00 | 9.34 | 21.32 | -- | 16.03 | 1.97 | 1.97 | 2.04 | 0.8648 | 0.719 | -- | -- | 1,186,515.00 | -4.50 | -53.67 | -5.49 | -58.89 | -- | -- | -6.26 | -949.54 | -- | -- | 0.00 | -- | -- | -- | 86.07 | -- | -- | -- |
| Context Therapeutics Inc | 0.00 | -21.32m | 153.00m | 5.00 | -- | 3.86 | -- | -- | -1.34 | -1.34 | 0.00 | 0.5288 | 0.00 | -- | -- | 0.00 | -99.14 | -- | -114.72 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -61.53 | -- | -- | -- |
| Capricor Therapeutics Inc | 27.10m | -24.31m | 153.33m | 101.00 | -- | 8.26 | -- | 5.66 | -0.8755 | -0.8755 | 0.9574 | 0.5834 | 0.5246 | -- | 59.13 | 268,299.50 | -47.07 | -54.12 | -122.20 | -75.13 | -- | -- | -89.72 | -316.25 | -- | -- | 0.1548 | -- | 886.81 | 72.02 | 23.20 | -- | 45.27 | -- |
| Repare Therapeutics Inc | 97.86m | -45.69m | 156.20m | 179.00 | -- | 0.6676 | -- | 1.60 | -1.10 | -1.10 | 2.30 | 5.51 | 0.3265 | -- | 9.22 | 546,698.30 | -15.25 | -23.40 | -18.73 | -26.37 | -- | -- | -46.69 | -162.76 | -- | -- | 0.00 | -- | -61.21 | -- | -222.91 | -- | 27.16 | -- |
| Vigil Neuroscience Inc | 0.00 | -82.78m | 157.48m | 65.00 | -- | 1.52 | -- | -- | -2.12 | -2.12 | 0.00 | 2.76 | 0.00 | -- | -- | 0.00 | -52.16 | -- | -54.92 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -20.98 | -- | -- | -- |
| Elevation Oncology Inc | 0.00 | -39.35m | 157.90m | 29.00 | -- | 1.97 | -- | -- | -1.03 | -1.03 | 0.00 | 1.47 | 0.00 | -- | -- | 0.00 | -42.35 | -- | -46.30 | -- | -- | -- | -- | -- | -- | -12.50 | 0.2889 | -- | -- | -- | 51.93 | -- | -- | -- |
| Kodiak Sciences Inc | 0.00 | -232.75m | 158.13m | 107.00 | -- | 0.6555 | -- | -- | -4.44 | -4.44 | 0.00 | 4.59 | 0.00 | -- | -- | 0.00 | -43.30 | -31.73 | -47.44 | -33.61 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 21.97 | -- | 134.76 | -- |
| Galectin Therapeutics Inc | 0.00 | -44.78m | 160.03m | 14.00 | -- | -- | -- | -- | -0.7373 | -0.7373 | 0.00 | -1.14 | 0.00 | -- | -- | 0.00 | -177.94 | -92.08 | -373.85 | -121.97 | -- | -- | -- | -- | -- | -10.24 | 7.25 | -- | -- | -- | -15.26 | -- | -- | -- |
| Quantum-Si Inc | 1.29m | -91.82m | 164.51m | 159.00 | -- | 0.6483 | -- | 128.02 | -0.6482 | -0.6482 | 0.0091 | 1.79 | 0.004 | 0.196 | 7.93 | 8,081.76 | -28.67 | -- | -29.50 | -- | 49.26 | -- | -7,145.76 | -- | 30.03 | -- | 0.00 | -- | -- | -- | 27.55 | -- | -- | -- |
| TriSalus Life Sciences Inc | 21.98m | -68.07m | 166.54m | 112.00 | -- | -- | -- | 7.58 | -2.09 | -2.09 | 0.7291 | -1.31 | 1.17 | 1.26 | 7.49 | 196,276.80 | -339.18 | -- | -11,196.50 | -- | 86.74 | -- | -291.08 | -- | 0.714 | -16.82 | -- | -- | 49.31 | -- | -26.51 | -- | -- | -- |
| Achieve Life Sciences Inc | 0.00 | -27.32m | 166.90m | 22.00 | -- | 3.37 | -- | -- | -1.29 | -1.29 | 0.00 | 1.44 | 0.00 | -- | -- | 0.00 | -60.15 | -86.31 | -109.37 | -119.59 | -- | -- | -- | -- | -- | -9.33 | 0.2574 | -- | -- | -- | 29.60 | -- | -14.51 | -- |
| Syros Pharmaceuticals Inc | 6.98m | -144.49m | 174.54m | 68.00 | -- | 11.59 | -- | 25.00 | -5.01 | -5.01 | 0.2244 | 0.5633 | 0.0411 | -- | -- | 102,661.80 | -84.98 | -54.44 | -103.51 | -64.32 | -- | -- | -2,069.80 | -772.82 | -- | -- | 0.7332 | -- | -33.23 | 37.12 | -73.87 | -- | -27.78 | -- |
| Atossa Therapeutics Inc | 0.00 | -29.69m | 174.80m | 10.00 | -- | 2.03 | -- | -- | -0.2359 | -0.2359 | 0.00 | 0.6833 | 0.00 | -- | -- | 0.00 | -28.65 | -29.97 | -29.84 | -32.55 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.62 | -- | -33.90 | -- |
| Puma Biotechnology Inc | 226.63m | 15.38m | 176.07m | 185.00 | 11.34 | 3.45 | 6.54 | 0.7769 | 0.3219 | 0.3219 | 4.74 | 1.06 | 1.10 | 10.95 | 8.13 | 1,225,016.00 | 7.49 | -12.21 | 11.65 | -20.53 | 73.44 | 78.78 | 6.78 | -11.79 | 1.38 | 2.57 | 0.6624 | -- | 3.34 | -1.25 | 1,079,450.00 | -- | 83.41 | -- |
| Skye Bioscience Inc | 0.00 | -37.50m | 177.11m | 11.00 | -- | 2.24 | -- | -- | -4.50 | -4.50 | 0.00 | 2.81 | 0.00 | -- | -- | 0.00 | -75.43 | -232.67 | -101.00 | -- | -- | -- | -- | -- | -- | -46.11 | 0.0552 | -- | -- | -- | -93.23 | -- | 23.38 | -- |
Data as of Jul 22 2024. Currency figures normalised to Quantum-Si Inc's reporting currency: US Dollar USD
38.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ARK Investment Management LLCas of 31 Mar 2024 | 12.77m | 10.48% |
| Nikko Asset Management Americas, Inc.as of 31 Mar 2024 | 8.05m | 6.61% |
| Nikko Asset Management Co., Ltd.as of 30 Jun 2024 | 7.86m | 6.45% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 6.36m | 5.22% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 5.22m | 4.28% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 2.16m | 1.77% |
| Geode Capital Management LLCas of 31 Mar 2024 | 2.13m | 1.75% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 822.34k | 0.68% |
| BlackRock Advisors LLCas of 31 Mar 2024 | 531.12k | 0.44% |
| Jacobs Levy Equity Management, Inc.as of 31 Mar 2024 | 506.70k | 0.42% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
